Deep-sited fungi infections
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age>18 years old 2. Experimental group included: patients diagnosed with confirmed/suspected IFD, CPA, Putative IFD, and available lesion specimens 3.Control group included: patients with hematological tumors receiving chemotherapy, granulocytopenia, immunosuppression (including solid organ transplantation or hematopoietic stem cell transplantation), or those with underlying lung diseases (including bronchiectasis, chronic obstructive pulmonary disease, etc.), as well as those with pulmonary infections or fever
Exclusion criteria
Exclusion criteria: 1.<18 years old; 2. Fungi cultures not submitted for testing 3. The specimen cannot meet the requirements for multiple PCR/CRISPR detection of fungi
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity of CRISPR/cas12-PCR;Specificity of CRISPR/cas12-PCR; | — |
Secondary
| Measure | Time frame |
|---|---|
| Test the consistency of CRISPR/cas12-PCR and Taqman probe microfluidic chip multiplex PCR; | — |
Countries
China
Contacts
Zhongshan hospital, Fudan University